The global market for Implantable Neurostimulation Devices was valued at US$ 5986 million in the year 2024 and is projected to reach a revised size of US$ 11700 million by 2031, growing at a CAGR of 10.2% during the forecast period.

Implantable Neurostimulation Devices Market

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

The Implantable Neurostimulation Devices market is primarily driven by the rising prevalence of neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and depression. As the global population ages, the incidence of these chronic conditions is increasing, creating a growing demand for effective and long-term treatment options. Implantable neurostimulators offer a promising solution for managing symptoms of these conditions, particularly for patients who have not responded to conventional therapies. Technological advancements in neurostimulation devices, such as more refined targeting mechanisms, smaller device sizes, and enhanced patient control, are also fueling market growth by improving treatment outcomes and patient satisfaction.

However, the market faces several challenges, including the high cost of implantable devices and the associated surgical procedures. These costs can limit accessibility, especially in low- and middle-income countries or healthcare systems with budget constraints. Additionally, while neurostimulators have shown positive results in treating various conditions, concerns remain regarding the long-term effectiveness, potential side effects, and device-related complications, such as battery life and the need for device replacements. The complexity of implantation and post-operative care also presents challenges for healthcare providers, requiring specialized training and resources, which may hinder broader adoption.

North America is the largest sales region of implantable neurostimulation devices, with market share nearly 42% in 2023. Europe is the second largest sales of implantable neurostimulation devices, enjoying market share nearly 29% in 2023. Medtronic, Boston Scientific, Abbott, LivaNova are the leading company, with the market share about 90%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulation Devices.

The Implantable Neurostimulation Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Neurostimulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Implantable Neurostimulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Implantable Neurostimulation Devices Market Report

Report Metric	Details
Report Name	Implantable Neurostimulation Devices Market
Accounted market size in year	US$ 5986 million
Forecasted market size in 2031	US$ 11700 million
CAGR	10.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Spinal Cord Stimulation (SCS) Gastric Electric Stimulation (GES) Deep Brain Stimulation (DBS) Sacral Nerve Stimulation (SNS) Vagus Nerve Stimulation (VNS) Others
Segment by Application	Parkinson’s Disease Epilepsy Pain Management Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Boston Scientific, Abbott, LivaNova, Nevro, Ruishenan Medical, Beijing Pins, Sceneray, Inspire Medical Systems, Nurotron
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Neurostimulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Implantable Neurostimulation Devices Market growing?

Ans: The Implantable Neurostimulation Devices Market witnessing a CAGR of 10.2% during the forecast period 2025-2031.

What is the Implantable Neurostimulation Devices Market size in 2031?

Ans: The Implantable Neurostimulation Devices Market size in 2031 will be US$ 11700 million.

What is the Implantable Neurostimulation Devices Market share by region?

Ans: North America is the largest sales region of implantable neurostimulation devices, with market share nearly 42% in 2023. Europe is the second largest sales of implantable neurostimulation devices, enjoying market share nearly 29% in 2023.

What is the Medtronic, Boston Scientific, Abbott, LivaNova share in Implantable Neurostimulation Devices Market?

Ans: Medtronic, Boston Scientific, Abbott, LivaNova are the leading company, with the market share about 90%.

Who are the main players in the Implantable Neurostimulation Devices Market report?

Ans: The main players in the Implantable Neurostimulation Devices Market are Medtronic, Boston Scientific, Abbott, LivaNova, Nevro, Ruishenan Medical, Beijing Pins, Sceneray, Inspire Medical Systems, Nurotron

What are the Application segmentation covered in the Implantable Neurostimulation Devices Market report?

Ans: The Applications covered in the Implantable Neurostimulation Devices Market report are Parkinson’s Disease, Epilepsy, Pain Management, Other

What are the Type segmentation covered in the Implantable Neurostimulation Devices Market report?

Ans: The Types covered in the Implantable Neurostimulation Devices Market report are Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Others

1 Implantable Neurostimulation Devices Market Overview

1.1 Product Definition

1.2 Implantable Neurostimulation Devices by Type

1.2.1 Global Implantable Neurostimulation Devices Market Value Comparison by Type (2024 VS 2031)

1.2.2 Spinal Cord Stimulation (SCS)

1.2.3 Gastric Electric Stimulation (GES)

1.2.4 Deep Brain Stimulation (DBS)

1.2.5 Sacral Nerve Stimulation (SNS)

1.2.6 Vagus Nerve Stimulation (VNS)

1.2.7 Others

1.3 Implantable Neurostimulation Devices by Application

1.3.1 Global Implantable Neurostimulation Devices Market Value by Application (2024 VS 2031)

1.3.2 Parkinson’s Disease

1.3.3 Epilepsy

1.3.4 Pain Management

1.3.5 Other

1.4 Global Implantable Neurostimulation Devices Market Size Estimates and Forecasts

1.4.1 Global Implantable Neurostimulation Devices Revenue 2020-2031

1.4.2 Global Implantable Neurostimulation Devices Sales 2020-2031

1.4.3 Global Implantable Neurostimulation Devices Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Implantable Neurostimulation Devices Market Competition by Manufacturers

2.1 Global Implantable Neurostimulation Devices Sales Market Share by Manufacturers (2020-2025)

2.2 Global Implantable Neurostimulation Devices Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Implantable Neurostimulation Devices Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Implantable Neurostimulation Devices, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Implantable Neurostimulation Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Implantable Neurostimulation Devices, Product Type & Application

2.7 Global Key Manufacturers of Implantable Neurostimulation Devices, Date of Enter into This Industry

2.8 Global Implantable Neurostimulation Devices Market Competitive Situation and Trends

2.8.1 Global Implantable Neurostimulation Devices Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Implantable Neurostimulation Devices Players Market Share by Revenue

2.8.3 Global Implantable Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Implantable Neurostimulation Devices Market Scenario by Region

3.1 Global Implantable Neurostimulation Devices Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Implantable Neurostimulation Devices Sales by Region: 2020-2031

3.2.1 Global Implantable Neurostimulation Devices Sales by Region: 2020-2025

3.2.2 Global Implantable Neurostimulation Devices Sales by Region: 2026-2031

3.3 Global Implantable Neurostimulation Devices Revenue by Region: 2020-2031

3.3.1 Global Implantable Neurostimulation Devices Revenue by Region: 2020-2025

3.3.2 Global Implantable Neurostimulation Devices Revenue by Region: 2026-2031

3.4 North America Implantable Neurostimulation Devices Market Facts & Figures by Country

3.4.1 North America Implantable Neurostimulation Devices Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Implantable Neurostimulation Devices Sales by Country (2020-2031)

3.4.3 North America Implantable Neurostimulation Devices Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Implantable Neurostimulation Devices Market Facts & Figures by Country

3.5.1 Europe Implantable Neurostimulation Devices Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Implantable Neurostimulation Devices Sales by Country (2020-2031)

3.5.3 Europe Implantable Neurostimulation Devices Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Implantable Neurostimulation Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Implantable Neurostimulation Devices Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Implantable Neurostimulation Devices Sales by Region (2020-2031)

3.6.3 Asia Pacific Implantable Neurostimulation Devices Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Implantable Neurostimulation Devices Market Facts & Figures by Country

3.7.1 Latin America Implantable Neurostimulation Devices Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Implantable Neurostimulation Devices Sales by Country (2020-2031)

3.7.3 Latin America Implantable Neurostimulation Devices Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Implantable Neurostimulation Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Implantable Neurostimulation Devices Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2020-2031)

3.8.3 Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Implantable Neurostimulation Devices Sales by Type (2020-2031)

4.1.1 Global Implantable Neurostimulation Devices Sales by Type (2020-2025)

4.1.2 Global Implantable Neurostimulation Devices Sales by Type (2026-2031)

4.1.3 Global Implantable Neurostimulation Devices Sales Market Share by Type (2020-2031)

4.2 Global Implantable Neurostimulation Devices Revenue by Type (2020-2031)

4.2.1 Global Implantable Neurostimulation Devices Revenue by Type (2020-2025)

4.2.2 Global Implantable Neurostimulation Devices Revenue by Type (2026-2031)

4.2.3 Global Implantable Neurostimulation Devices Revenue Market Share by Type (2020-2031)

4.3 Global Implantable Neurostimulation Devices Price by Type (2020-2031)

5 Segment by Application

5.1 Global Implantable Neurostimulation Devices Sales by Application (2020-2031)

5.1.1 Global Implantable Neurostimulation Devices Sales by Application (2020-2025)

5.1.2 Global Implantable Neurostimulation Devices Sales by Application (2026-2031)

5.1.3 Global Implantable Neurostimulation Devices Sales Market Share by Application (2020-2031)

5.2 Global Implantable Neurostimulation Devices Revenue by Application (2020-2031)

5.2.1 Global Implantable Neurostimulation Devices Revenue by Application (2020-2025)

5.2.2 Global Implantable Neurostimulation Devices Revenue by Application (2026-2031)

5.2.3 Global Implantable Neurostimulation Devices Revenue Market Share by Application (2020-2031)

5.3 Global Implantable Neurostimulation Devices Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medtronic Implantable Neurostimulation Devices Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Boston Scientific

6.2.1 Boston Scientific Company Information

6.2.2 Boston Scientific Description and Business Overview

6.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Boston Scientific Implantable Neurostimulation Devices Product Portfolio

6.2.5 Boston Scientific Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Implantable Neurostimulation Devices Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 LivaNova

6.4.1 LivaNova Company Information

6.4.2 LivaNova Description and Business Overview

6.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.4.4 LivaNova Implantable Neurostimulation Devices Product Portfolio

6.4.5 LivaNova Recent Developments/Updates

6.5 Nevro

6.5.1 Nevro Company Information

6.5.2 Nevro Description and Business Overview

6.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Nevro Implantable Neurostimulation Devices Product Portfolio

6.5.5 Nevro Recent Developments/Updates

6.6 Ruishenan Medical

6.6.1 Ruishenan Medical Company Information

6.6.2 Ruishenan Medical Description and Business Overview

6.6.3 Ruishenan Medical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Ruishenan Medical Implantable Neurostimulation Devices Product Portfolio

6.6.5 Ruishenan Medical Recent Developments/Updates

6.7 Beijing Pins

6.7.1 Beijing Pins Company Information

6.7.2 Beijing Pins Description and Business Overview

6.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Beijing Pins Implantable Neurostimulation Devices Product Portfolio

6.7.5 Beijing Pins Recent Developments/Updates

6.8 Sceneray

6.8.1 Sceneray Company Information

6.8.2 Sceneray Description and Business Overview

6.8.3 Sceneray Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sceneray Implantable Neurostimulation Devices Product Portfolio

6.8.5 Sceneray Recent Developments/Updates

6.9 Inspire Medical Systems

6.9.1 Inspire Medical Systems Company Information

6.9.2 Inspire Medical Systems Description and Business Overview

6.9.3 Inspire Medical Systems Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Inspire Medical Systems Implantable Neurostimulation Devices Product Portfolio

6.9.5 Inspire Medical Systems Recent Developments/Updates

6.10 Nurotron

6.10.1 Nurotron Company Information

6.10.2 Nurotron Description and Business Overview

6.10.3 Nurotron Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Nurotron Implantable Neurostimulation Devices Product Portfolio

6.10.5 Nurotron Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Implantable Neurostimulation Devices Industry Chain Analysis

7.2 Implantable Neurostimulation Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Implantable Neurostimulation Devices Production Mode & Process Analysis

7.4 Implantable Neurostimulation Devices Sales and Marketing

7.4.1 Implantable Neurostimulation Devices Sales Channels

7.4.2 Implantable Neurostimulation Devices Distributors

7.5 Implantable Neurostimulation Devices Customer Analysis

8 Implantable Neurostimulation Devices Market Dynamics

8.1 Implantable Neurostimulation Devices Industry Trends

8.2 Implantable Neurostimulation Devices Market Drivers

8.3 Implantable Neurostimulation Devices Market Challenges

8.4 Implantable Neurostimulation Devices Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Inspire Medical Systems

NUROTRON

List of Tables

Table 1. Global Implantable Neurostimulation Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Implantable Neurostimulation Devices Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Implantable Neurostimulation Devices Market Competitive Situation by Manufacturers in 2024

Table 4. Global Implantable Neurostimulation Devices Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Implantable Neurostimulation Devices Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Implantable Neurostimulation Devices Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Implantable Neurostimulation Devices Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Implantable Neurostimulation Devices Average Price (K USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Implantable Neurostimulation Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Implantable Neurostimulation Devices, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Implantable Neurostimulation Devices, Product Type & Application

Table 12. Global Key Manufacturers of Implantable Neurostimulation Devices, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Implantable Neurostimulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neurostimulation Devices as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Implantable Neurostimulation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Implantable Neurostimulation Devices Sales by Region (2020-2025) & (Units)

Table 18. Global Implantable Neurostimulation Devices Sales Market Share by Region (2020-2025)

Table 19. Global Implantable Neurostimulation Devices Sales by Region (2026-2031) & (Units)

Table 20. Global Implantable Neurostimulation Devices Sales Market Share by Region (2026-2031)

Table 21. Global Implantable Neurostimulation Devices Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Implantable Neurostimulation Devices Revenue Market Share by Region (2020-2025)

Table 23. Global Implantable Neurostimulation Devices Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Implantable Neurostimulation Devices Revenue Market Share by Region (2026-2031)

Table 25. North America Implantable Neurostimulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)

Table 27. North America Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)

Table 28. North America Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Implantable Neurostimulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)

Table 32. Europe Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)

Table 33. Europe Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Implantable Neurostimulation Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Implantable Neurostimulation Devices Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Implantable Neurostimulation Devices Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Implantable Neurostimulation Devices Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Implantable Neurostimulation Devices Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Implantable Neurostimulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)

Table 42. Latin America Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)

Table 43. Latin America Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Implantable Neurostimulation Devices Sales (Units) by Type (2020-2025)

Table 51. Global Implantable Neurostimulation Devices Sales (Units) by Type (2026-2031)

Table 52. Global Implantable Neurostimulation Devices Sales Market Share by Type (2020-2025)

Table 53. Global Implantable Neurostimulation Devices Sales Market Share by Type (2026-2031)

Table 54. Global Implantable Neurostimulation Devices Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Implantable Neurostimulation Devices Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2020-2025)

Table 57. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2026-2031)

Table 58. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Type (2020-2025)

Table 59. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Type (2026-2031)

Table 60. Global Implantable Neurostimulation Devices Sales (Units) by Application (2020-2025)

Table 61. Global Implantable Neurostimulation Devices Sales (Units) by Application (2026-2031)

Table 62. Global Implantable Neurostimulation Devices Sales Market Share by Application (2020-2025)

Table 63. Global Implantable Neurostimulation Devices Sales Market Share by Application (2026-2031)

Table 64. Global Implantable Neurostimulation Devices Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Implantable Neurostimulation Devices Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2020-2025)

Table 67. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2026-2031)

Table 68. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Application (2020-2025)

Table 69. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Application (2026-2031)

Table 70. Medtronic Company Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 73. Medtronic Implantable Neurostimulation Devices Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Boston Scientific Company Information

Table 76. Boston Scientific Description and Business Overview

Table 77. Boston Scientific Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 78. Boston Scientific Implantable Neurostimulation Devices Product

Table 79. Boston Scientific Recent Developments/Updates

Table 80. Abbott Company Information

Table 81. Abbott Description and Business Overview

Table 82. Abbott Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 83. Abbott Implantable Neurostimulation Devices Product

Table 84. Abbott Recent Developments/Updates

Table 85. LivaNova Company Information

Table 86. LivaNova Description and Business Overview

Table 87. LivaNova Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 88. LivaNova Implantable Neurostimulation Devices Product

Table 89. LivaNova Recent Developments/Updates

Table 90. Nevro Company Information

Table 91. Nevro Description and Business Overview

Table 92. Nevro Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 93. Nevro Implantable Neurostimulation Devices Product

Table 94. Nevro Recent Developments/Updates

Table 95. Ruishenan Medical Company Information

Table 96. Ruishenan Medical Description and Business Overview

Table 97. Ruishenan Medical Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 98. Ruishenan Medical Implantable Neurostimulation Devices Product

Table 99. Ruishenan Medical Recent Developments/Updates

Table 100. Beijing Pins Company Information

Table 101. Beijing Pins Description and Business Overview

Table 102. Beijing Pins Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 103. Beijing Pins Implantable Neurostimulation Devices Product

Table 104. Beijing Pins Recent Developments/Updates

Table 105. Sceneray Company Information

Table 106. Sceneray Description and Business Overview

Table 107. Sceneray Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 108. Sceneray Implantable Neurostimulation Devices Product

Table 109. Sceneray Recent Developments/Updates

Table 110. Inspire Medical Systems Company Information

Table 111. Inspire Medical Systems Description and Business Overview

Table 112. Inspire Medical Systems Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 113. Inspire Medical Systems Implantable Neurostimulation Devices Product

Table 114. Inspire Medical Systems Recent Developments/Updates

Table 115. Nurotron Company Information

Table 116. Nurotron Description and Business Overview

Table 117. Nurotron Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)

Table 118. Nurotron Implantable Neurostimulation Devices Product

Table 119. Nurotron Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Implantable Neurostimulation Devices Distributors List

Table 123. Implantable Neurostimulation Devices Customers List

Table 124. Implantable Neurostimulation Devices Market Trends

Table 125. Implantable Neurostimulation Devices Market Drivers

Table 126. Implantable Neurostimulation Devices Market Challenges

Table 127. Implantable Neurostimulation Devices Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Implantable Neurostimulation Devices

Figure 2. Global Implantable Neurostimulation Devices Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Implantable Neurostimulation Devices Market Share by Type: 2024 & 2031

Figure 4. Spinal Cord Stimulation (SCS) Product Picture

Figure 5. Gastric Electric Stimulation (GES) Product Picture

Figure 6. Deep Brain Stimulation (DBS) Product Picture

Figure 7. Sacral Nerve Stimulation (SNS) Product Picture

Figure 8. Vagus Nerve Stimulation (VNS) Product Picture

Figure 9. Others Product Picture

Figure 10. Global Implantable Neurostimulation Devices Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Implantable Neurostimulation Devices Market Share by Application: 2024 & 2031

Figure 12. Parkinson’s Disease

Figure 13. Epilepsy

Figure 14. Pain Management

Figure 15. Other

Figure 16. Global Implantable Neurostimulation Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Implantable Neurostimulation Devices Market Size (2020-2031) & (US$ Million)

Figure 18. Global Implantable Neurostimulation Devices Sales (2020-2031) & (Units)

Figure 19. Global Implantable Neurostimulation Devices Average Price (K USD/Unit) & (2020-2031)

Figure 20. Implantable Neurostimulation Devices Report Years Considered

Figure 21. Implantable Neurostimulation Devices Sales Share by Manufacturers in 2024

Figure 22. Global Implantable Neurostimulation Devices Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Implantable Neurostimulation Devices Players: Market Share by Revenue in Implantable Neurostimulation Devices in 2024

Figure 24. Implantable Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Implantable Neurostimulation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Implantable Neurostimulation Devices Sales Market Share by Country (2020-2031)

Figure 27. North America Implantable Neurostimulation Devices Revenue Market Share by Country (2020-2031)

Figure 28. U.S. Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Implantable Neurostimulation Devices Sales Market Share by Country (2020-2031)

Figure 31. Europe Implantable Neurostimulation Devices Revenue Market Share by Country (2020-2031)

Figure 32. Germany Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Implantable Neurostimulation Devices Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Implantable Neurostimulation Devices Revenue Market Share by Region (2020-2031)

Figure 39. China Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. China Taiwan Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Implantable Neurostimulation Devices Sales Market Share by Country (2020-2031)

Figure 49. Latin America Implantable Neurostimulation Devices Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Implantable Neurostimulation Devices Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. UAE Implantable Neurostimulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Implantable Neurostimulation Devices by Type (2020-2031)

Figure 59. Global Revenue Market Share of Implantable Neurostimulation Devices by Type (2020-2031)

Figure 60. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Implantable Neurostimulation Devices by Application (2020-2031)

Figure 62. Global Revenue Market Share of Implantable Neurostimulation Devices by Application (2020-2031)

Figure 63. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Application (2020-2031)

Figure 64. Implantable Neurostimulation Devices Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions